ATAI - CIK 0001840904
The table below shows ATAI Life Sciences N.V.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash & equivalents | $17.50M | $45.03M | $190.61M | $362.27M |
| Short-term investments | - | - | - | - |
| Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $80.13M | $185.59M | $287.14M | $375.08M |
| Property, plant & equipment | $2.54M | $981.00K | $928.00K | $149.00K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | $331.00K | - | - | - |
| Total assets | $159.39M | $293.48M | $305.44M | $414.17M |
| Accounts payable | $2.62M | $4.59M | $2.40M | $6.00M |
| Total current liabilities | $24.95M | $20.12M | $19.90M | $20.93M |
| Long-term debt | $14.13M | $15.05M | $14.70M | - |
| Total liabilities | $42.83M | $49.16M | $39.67M | $28.21M |
| Retained earnings | -$700.21M | -$550.94M | -$510.19M | -$357.80M |
| Total equity | $116.30M | $242.96M | $260.74M | $376.91M |